MedPath

A study to compare the efficacy in terms of preventing disease recurrence; and safety in terms of drug related side effects of Mycophenolate mofetil in comparison with Levamisole in children with difficult to treat nephrotic syndrome, a chronic protein loosing kidney disease.

Phase 3
Completed
Conditions
Health Condition 1: null- Nephrotic Syndrome
Registration Number
CTRI/2013/10/004107
Lead Sponsor
ilratan Sircar Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Children between 2years and16 years with FRNS with or without steroid dependency.

Estimated glomerular filtration rate (eGFR) >80 ml/min per 1.73 m2.

Children in remission at study entry (trace or nil proteinuria, as determined by the dipstick test or <100 mg/dl for at least 3 days).

No previous use of any steroid sparing agent.

Informed cosent.

Exclusion Criteria

Patients with severe leucopenia (leucocytes less than 3.0Ã? 1000 cells/mm3), severe anemia (haemoglobin less than 8.9 g/dl) or any active infection.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath